Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Sign up for one of our free Webinars to learn about basic and advanced science topics, get tips and techniques for your lab, or find out more about new technologies and products. Webinars cover educational topics in life science research, drug discovery, clinical research, applied sciences, clinical and molecular diagnostics, and more. Live presentations include the opportunity to ask questions via chat. Don't worry if you missed a presentation date—past Webinars are available for on-demand viewing. 

Upcoming Webinars

Bioanalytical Tools for Biosimilar Development

Biologic therapeutics have revolutionized the treatment of cancer and immune-mediated inflammatory diseases. Because of the complex structure and inherently variable processes by which innovator biologic and biosimilar drugs are manufactured, robust characterization tools are essential. In this webinar, we will explore analytical tools that enable drug developers to bring biosimilar therapeutics to market. The webinar will include a live Q&A session.

Presenter:
Jeff Nelson, PhD, Biologics Product Manager, Promega

Dates:
Wednesday, August 10, 2022 - 9am CDT / 10am EDT / 3pm London / 4pm Amsterdam-Paris
Thursday, August 11, 2022 - 12pm Singapore / 2pm Sydney / 1pm Seoul / 9:30am New Delhi

Register Here:

Wednesday, August 10Thursday, August 11

Implementing Digital PCR for Wastewater Disease Surveillance

Wastewater is a challenging matrix for establishing consistent molecular biology methods. Since the COVID-19 pandemic, wastewater surveillance has been widely accepted as an economical and unbiased tool for surveillance of outbreaks and disease dynamics in a population. As a result, methods for wastewater sample preparation and PCR detection are constantly being improved and optimized. Join us for this webinar where we will discuss the direct capture concentration and purification method in combination with digital PCR for quantifying SARS-CoV-2 levels in wastewater and tracking of variant circulation. We will also demonstrate how new data generated with improved methods can be matched to historical trending results.

Presenters:
Brigitta Saul, PhD, Sr. Global Commercialization and Marketing Manager, Promega Corporation
Martin Becker, PhD, Application Specialist, Stilla Technologies
Timothy R. Julian, PhD, Group Leader, Environmental Microbiology, Eawag

Dates:
Thursday, September 22, 2022 @ 10am CDT / 11am EDT / 4pm London / 5pm Amsterdam-Paris
Friday, September 23, 2022 @ 12pm Singapore / 2pm Sydney / 1pm Seoul / 9:30am New Delhi

Register Here:

Thursday, September 22Friday, September 23

Resetting Expectations for CAR-T Potency Assessment – A Novel Target-Cell Killing Based Approach

Potency assays are an essential aspect of analyses of biotherapeutics, including CAR-T therapeutics. The potency assay format that will be used as a release assay for CTM (in a QC environment) needs to be as accurate, precise and robust as possible. Developing a robust potency assay for CAR-T therapeutics can be a long and complicated process. The mechanism of action of CAR-T cells – dubbed ‘living drugs’ – in-vivo is multi-faceted. Currently, target-cell killing and cytokine induction are two of the more prominent measures indicative of CAR-T potency in the cell therapy field. This webinar will provide the rationale and data that supports transitioning from current interpolation-based cytokine induction assays, with minimal number of dilutions (one), to full-curve analyses based upon MOA-reflective cellular responses.

In this webinar, you will learn about:

  • Limitations of existing CAR-T potency measurement approaches
  • A new HiBiT target-cell killing based approach for CAR-T potency assessment
  • Evaluation of HiBiT target-cell killing assay performance for use in a QC environment

Presenter:
Avinash Chinthala, Scientist, CMC Analytical Development, Precision BioSciences Inc.

Dates:
Wednesday, October 5, 2022 @ 10am CDT / 11am EDT / 4pm London / 5pm Amsterdam-Paris
Thursday, October 6, 2022 @ 12pm Singapore / 2pm Sydney / 1pm Seoul / 9:30am New Delhi

Register Here:

Wednesday, October 5Thursday, October 6

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up

Search On-Demand Webinars